{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A phase 1 study of JNJ-86974680, an A2a receptor antagonist, administered as monotherapy and in combination with cetrelimab and radiotherapy for advanced nonsmall cell lung cancer","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-1-study-of-jnj-86974680-an-a2a-receptor-antagonist-administered-as-monotherapy-and-in-combination-with-cetrelimab-and-radiotherapy-for-advanced-nonsmall-cell-lung-cancer\/#breadcrumbitem"}]}